Suchergebnisse - "Greig, Nigel H"

PubPharm (233)

1

Repurposing Pomalidomide as a Neuroprotective Drug: Efficacy in an Alpha-Synuclein-Based Model of Parkinson’s Disease

enthalten in: Neurotherapeutics | 2022

von Palmas, M. | Ena, A. | Burgaletto, C. | +16

2

Role of viruses, prions and miRNA in neurodegenerative disorders and dementia

enthalten in: Indian journal of virology | 2018

von Sohrab, S. | Suhail, M. | Ali, A. | +5

3

Novel GLP-1R/GIPR co-agonist “twincretin” is neuroprotective in cell and rodent models of mild traumatic brain injury

enthalten in: Experimental neurology | 2017

von Tamargo, I. | Bader, M. | Li, Y. | +6

4

Neurotrophic and neuroprotective effects of oxyntomodulin in neuronal cells and a rat model of stroke

enthalten in: Experimental neurology | 2017

von Li, Y. | Wu, K. | Yu, S. | +3

5

Mitophagy and Alzheimer’s Disease: Cellular and Molecular Mechanisms

enthalten in: Trends in neurosciences | 2017

von Kerr, J. | Adriaanse, B. | Greig, N. | +4

6

Mitophagy and Alzheimer's Disease: Cellular and Molecular Mechanisms

enthalten in: Trends in neurosciences | 2017

von Greig, N. | Bohr, V. | Mattson, M. | +4

7

A New Treatment Strategy for Parkinson's Disease through the Gut–Brain Axis

enthalten in: Cell transplantation | 2017

von Kim, D. | Choi, H. | Wang, Y. | +3

8

Neuroprotective Mechanisms Mediated by CDK5 Inhibition

enthalten in: Current pharmaceutical design | 2016

von Greig, N. | Al-Abbasi, F. | Mushtaq, G. | +4

9

Editorial: Managing Strategies for Diverse Diseases: Challenges from Bench to Bedside Translation in Successful Drug Discovery and Development

enthalten in: Current pharmaceutical design | 2016

von Kamal, M. | Greig, N.

10

Blast traumatic brain injury-induced cognitive deficits are attenuated by preinjury or postinjury treatment with the glucagon-like peptide-1 receptor agonist, exendin-4

enthalten in: Alzheimer's & dementia | 2016

von Greig, N. | Tweedie, D. | Holloway, H. | +9

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[24]